[Transforming growth factor β in prostate cancer: cellular effects and basic molecular mechanisms]

Area of Science:

• Molecular Biology
• Oncology
• Cell Signaling

Context:

• Prostate cancer (PCa) is a complex disease where the cytokine transforming growth factor beta (TGFβ) exhibits a dual role.
• TGFβ presents both anti-oncogenic (growth inhibition, apoptosis) and pro-oncogenic (proliferation, motility, microenvironment remodeling) properties in PCa.
• In advanced PCa, TGFβ loses its tumor-suppressive functions, adopting a tumorigenic phenotype.

Purpose:

• To elucidate the molecular mechanisms and signaling pathways underlying the role of TGFβ in prostate cancer progression.
• To investigate the shift in TGFβ function from tumor suppression to tumor promotion in later stages of PCa.
• To understand the cross-talk between TGFβ signaling and other key pathways like MAPK and AR signaling in PCa pathogenesis.

Summary:

• TGFβ is a multifunctional cytokine with opposing roles in prostate cancer, influencing cell growth and tumorigenesis.
• The cytokine's function transitions in later stages of PCa, where it promotes tumor progression rather than inhibiting it.
• This functional shift is largely driven by the intricate cross-talk between TGFβ signaling and other proliferation pathways, including MAPK and AR signaling.

Impact:

• Understanding the complex role of TGFβ in PCa molecular pathology can reveal novel therapeutic targets.
• Elucidating TGFβ's signaling network interactions may lead to strategies to restore its tumor-suppressive functions.
• This research contributes to a deeper comprehension of prostate cancer development and progression at the molecular level.